EDGAR Filing Documents for 0001193125-17-106715

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-17-106715

Filing Date

2017-03-31

Accepted

2017-03-31 16:47:21

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d365319ds3.htm	S-3	463684
2	EX-4.3	d365319dex43.htm	EX-4.3	312661
3	EX-4.5	d365319dex45.htm	EX-4.5	109667
4	EX-5.1	d365319dex51.htm	EX-5.1	28658
5	EX-23.1	d365319dex231.htm	EX-23.1	1626
6	EX-23.2	d365319dex232.htm	EX-23.2	1866
7	GRAPHIC	g365319g0329094025838.jpg	GRAPHIC	2722
8	GRAPHIC	g365319g25x93.jpg	GRAPHIC	35644
	Complete submission text file	0001193125-17-106715.txt		972402

Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301

Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952

MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-217084 | Film No.: 17731005
SIC: 8071 Services-Medical Laboratories